Leukemia & Lymphoma, Volume 64, Issue 10 (2023)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 64, Issue 10 (2023)

See all volumes and issues
Vol 65, 2024 Volume 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs Download issue

Commentary

Lenalidomide maintenance in Myeloma – a goldilocks problem?
Melissa Ng Liet Hing & Amit Khot
Pages: 1611-1614
Published online: 06 Sep 2023
First Page PreviewforLenalidomide maintenance in Myeloma – a goldilocks problem? | Full Text | References | PDF (426.8 KB) | EPUB
  • 122 Views
  • 0 CrossRef citations
  • 0Altmetric

Reviews

Review Article
Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: a review
Franco Locatelli, Bijal Shah, Tracy Thomas, Kelly Velasco, Babatunde Adedokun, Ibrahim Aldoss, Lia Gore, Dieter Hoelzer, Renato Bassan, Jae H. Park, Nicolas Boissel & Hagop Kantarjian
Pages: 1615-1633
Published online: 01 Aug 2023
AbstractforIncidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: a review | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 491 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Articles

Article
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study
Emanuele Cencini, Anna Sicuranza, Alberto Fabbri, Cristina Marzano, Paola Pacelli, Federico Caroni, Donatella Raspadori & Monica Bocchia
Pages: 1634-1642
Published online: 09 Jul 2023
AbstractforThe prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study | Full Text | References | PDF (791.5 KB) | EPUB | Supplemental
  • 173 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Comparative effectiveness of salvage chemotherapy regimens and chimeric antigen T-cell receptor therapies in relapsed and refractory diffuse large B cell lymphoma: a network meta-analysis of clinical trials
Inna Y. Gong, Mahmood Aminilari, Ivan Landego, Katrina Hueniken, Qianghua Zhou, John Kuruvilla & David C. Hodgson
Pages: 1643-1654
Published online: 07 Aug 2023
AbstractforComparative effectiveness of salvage chemotherapy regimens and chimeric antigen T-cell receptor therapies in relapsed and refractory diffuse large B cell lymphoma: a network meta-analysis of clinical trials | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 2189 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European center
Miguel Arguello-Tomas, Nil Albiol, Paola Jara, Irene Garcia-Cadenas, Sara Redondo, Albert Esquirol, Silvana Novelli, Silvana Saavedra, Rodrigo Martino, Josep Nomdedeu, Jordi Sierra, Alba Mora & Carol Moreno
Pages: 1655-1661
Published online: 15 Jul 2023
AbstractforEvolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European center | Full Text | References | PDF (2.4 MB) | EPUB | Supplemental
  • 145 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Acute myeloid leukemias with JAK2/STAT mutations are associated with PD-L1 upregulation
Jiani Chai, Jui Choudhuri, Qing Wang, Yanan Fang, Yang Shi, Josette Kamel, Nishi Shah, R. Alejandro Sica, Noah Kornblum, Marina Konopleva, Ioannis Mantzaris, Aditi Shastri, Kira Gritsman, Amit Verma, Mendel Goldfinger, Swati Goel, Yanhua Wang & Xuejun Tian
Pages: 1662-1672
Published online: 10 Jul 2023
AbstractforAcute myeloid leukemias with JAK2/STAT mutations are associated with PD-L1 upregulation | Full Text | References | PDF (6.8 MB) | EPUB | Supplemental
  • 219 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Utility of end of induction bone marrow biopsy and survival outcomes in acute promyelocytic leukemia treated with fixed-dose induction regimen
Sydney Dunn-Valadez, Srilakshmi Bathini, Kathleen E. Purdy, Kimo Bachiashvili, Ravi Bhatia, Omer Jamy, Sravanti Rangaraju, Amitkumar Mehta, Kelly Godby, Gaurav Goyal, Sarah Worth, Josh D. Oliver, Fady M. Mikhail, John K. Choi, Diana Morlote, Vishnu B. Reddy & Pankit Vachhani
Pages: 1673-1680
Published online: 26 Jul 2023
AbstractforUtility of end of induction bone marrow biopsy and survival outcomes in acute promyelocytic leukemia treated with fixed-dose induction regimen | Full Text | References | PDF (1.2 MB) | EPUB
  • 140 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Integrated genomic and single-cell transcriptomic analyses reveal clonal evolution and immune signature in donor cell leukemia after haploidentical allogeneic hematopoietic stem cell transplantation
Huiqiao Chen, Xiujie Zhao, Wenjue Pan & Haowen Xiao
Pages: 1681-1688
Published online: 10 Jul 2023
AbstractforIntegrated genomic and single-cell transcriptomic analyses reveal clonal evolution and immune signature in donor cell leukemia after haploidentical allogeneic hematopoietic stem cell transplantation | Full Text | References | PDF (3 MB) | EPUB | Supplemental
  • 196 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
A retrospective validation of the IPSS-M molecular score in primary and therapy-related myelodysplastic syndromes (MDS)
Jean M. G. Sabile, Andy Kaempf, Kaitlyn Tomic, Gurusidda P. Manu, Ronan Swords & Yazan Migdady
Pages: 1689-1694
Published online: 13 Jul 2023
AbstractforA retrospective validation of the IPSS-M molecular score in primary and therapy-related myelodysplastic syndromes (MDS) | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 236 Views
  • 1 CrossRef citations
  • 0Altmetric

Letters to the Editor

Prolonged 3-year spontaneous remission of diffuse large B-cell lymphoma upon withdrawal of infliximab and late relapse in a patient with psoriasis: a case report and review of the literature
John V. Asimakopoulos, Filippos Dolkiras, Eleftheria Lakiotaki, Phivi Rondogianni, Gerasimos Tsourouflis, Marina P. Siakantaris, Maria K. Angelopoulou, Dimitra Rondogianni, Penelope Korkolopoulou, Panayiotis Vlahoyiannopoulos & Theodoros P. Vassilakopoulos
Pages: 1695-1700
Published online: 26 Jul 2023
First Page PreviewforProlonged 3-year spontaneous remission of diffuse large B-cell lymphoma upon withdrawal of infliximab and late relapse in a patient with psoriasis: a case report and review of the literature | Full Text | References | PDF (4.5 MB) | EPUB
  • 142 Views
  • 0 CrossRef citations
  • 0Altmetric
B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature
I. Arribas, C. Maluquer, H. Pomares, I. Carro, C. Baca, A. Bosch, C. E. Arévalo, C. Montané, J. Ribes-Amorós, L. Zamora, I. Granada, E. Gamundi, M. Arnan & A. Sureda
Pages: 1701-1705
Published online: 17 Jul 2023
First Page PreviewforB-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature | Full Text | References | PDF (398.5 KB) | EPUB | Supplemental
  • 185 Views
  • 1 CrossRef citations
  • 0Altmetric
Robust prognostic value of histologic transformation in patients with early progression of follicular lymphoma
Takafumi Shichijo, Hiro Tatetsu, Kisato Nosaka, Yusuke Higuchi, Yoshitaka Kikukawa, Kosuke Toyoda, Shinya Shiraishi, Jun-ichirou Yasunaga & Masao Matsuoka
Pages: 1706-1710
Published online: 30 Jun 2023
First Page PreviewforRobust prognostic value of histologic transformation in patients with early progression of follicular lymphoma | Full Text | References | PDF (685.5 KB) | EPUB | Supplemental
  • 972 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Aberrant expression of CD5 in adult acute myeloid leukemia belonged to AML-MR, may represent a uniquely aggressive subcategory
Yan Zhang, Yuanyi Ding, Rui Zhang, Lijun Zhang, Xiaojing Yan & Pingping Wang
Pages: 1711-1714
Published online: 03 Jul 2023
First Page PreviewforAberrant expression of CD5 in adult acute myeloid leukemia belonged to AML-MR, may represent a uniquely aggressive subcategory | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 95 Views
  • 1 CrossRef citations
  • 0Altmetric
Real-world evidence on the use of daratumumab, bortezomib and dexamethasone (DVd) in lenalidomide-refractory myeloma patients: subgroup analysis of the multicenter retrospective experience by “rete ematologica pugliese”
Giuseppe Mele, Nicola Di Renzo, Nicola Cascavilla, Angelo Michele Carella, Attilio Guarini, Patrizio Mazza, Lorella Melillo, Vincenzo Pavone, Giuseppe Tarantini, Paola Curci, Anna P. Falcone, Candida Germano, Anna Mele, Francesca Merchionne, Giulia Palazzo, Gaetano Palumbo, Angela Maria Quinto, Giovanni Reddiconto, Bernardo Rossini, Alessandro Spina, Nicola Sgherza, Giorgina Specchia, Pellegrino Musto & Domenico Pastore
Pages: 1715-1718
Published online: 07 Jul 2023
First Page PreviewforReal-world evidence on the use of daratumumab, bortezomib and dexamethasone (DVd) in lenalidomide-refractory myeloma patients: subgroup analysis of the multicenter retrospective experience by “rete ematologica pugliese” | Full Text | References | PDF (628.5 KB) | EPUB
  • 235 Views
  • 0 CrossRef citations
  • 0Altmetric
Non-hepatosplenic extramedullary manifestations in patients affected by Chronic myelomonocytic leukemia. Case report and meta-analysis of the published series
A. M. E. Maraglino, V. Amato, S. Sammassimo, F. Gigli, V. Tabanelli, R. Pastano, C. Tarella, F. Giglio & E. Derenzini
Pages: 1719-1722
Published online: 14 Jul 2023
First Page PreviewforNon-hepatosplenic extramedullary manifestations in patients affected by Chronic myelomonocytic leukemia. Case report and meta-analysis of the published series | Full Text | References | PDF (2.3 MB) | EPUB | Supplemental
  • 99 Views
  • 0 CrossRef citations
  • 0Altmetric
Ruxolitinib: a new first-line strategy in autoimmune myelofibrosis treatment
Domenico Penna, Alessia Tieghi, Riccardo Valli & Francesco Merli
Pages: 1723-1726
Published online: 13 Jul 2023
First Page PreviewforRuxolitinib: a new first-line strategy in autoimmune myelofibrosis treatment | Full Text | References | PDF (3.8 MB) | EPUB
  • 130 Views
  • 0 CrossRef citations
  • 0Altmetric
The efficacy of tixagevimab–cilgavimab prophylaxis against Omicron BA.5 variants in patients with hematological malignancies: insights from the Leukemia and Lymphoma Society Registry
Efrat Luttwak, Ariela Noy, Venkatraman Seshan, Larry A. Saltzman & Lee M. Greenberger
Pages: 1727-1729
Published online: 29 Jun 2023
First Page PreviewforThe efficacy of tixagevimab–cilgavimab prophylaxis against Omicron BA.5 variants in patients with hematological malignancies: insights from the Leukemia and Lymphoma Society Registry | Full Text | References | PDF (493.5 KB) | EPUB | Supplemental
  • 90 Views
  • 0 CrossRef citations
  • 0Altmetric
CCND2 mutations in atypical chronic myeloid leukemia: a report of two cases
Giovanni Iaquinta, Emilia Scalzulli, Silvia Angeloni, Ida Carmosino, Alessandro Costa, Claudia Ielo, Mauro Passucci, Chiara Masucci, Maurizio Martelli, Paola Grammatico & Massimo Breccia
Pages: 1730-1732
Published online: 12 Jul 2023
AbstractforCCND2 mutations in atypical chronic myeloid leukemia: a report of two cases | Full Text | References | PDF (645.6 KB) | EPUB | Supplemental
  • 113 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

High red cell mass and high plasma volume are independently associated with thrombotic risk in polycythemia vera
Ivan Krecak et al.
Letter to the Editor | Published online: 20 Jun 2024
Experience of using venetoclax in relapsed T- cell lymphoma
Jasmine Zain et al.
Letter to the Editor | Published online: 17 Jun 2024
Therapy-related myeloid neoplasms with single-hit TP53 mutations share the clinical, molecular, and survival characteristics of their multi-hit counterparts
Taylor Zak et al.
Article | Published online: 17 Jun 2024
Polycythemia vera: past, present and future
Ami B. Patel et al.
Review Article | Published online: 13 Jun 2024
View all latest articles